Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis
Postępy Biochemii · 2016
DOI: 10.18388/pb.2016_37 ↗Kurz gefasst
Fachartikel in der Zeitschrift Postępy Biochemii, 2016. Verfasst von Smriti Sangwan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 28-mal zitiert (Crossref).
Abstract (Originalsprache)
A myotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive degeneration of spinal motor neurons. Although mutations in dozens of proteins have been associated with ALS, the enzyme, superoxide dismutase 1 (SOD1) was the first protein identified with the development of ALS and accounts for ~20% of familial cases. In experimental animals and patient samples, mutant SOD1 is found in cytoplasmic deposits implicating SOD1 aggregates as the toxic entities. Here we discuss the various biochemical and structure-based hypotheses proposed for mutant SOD1-associated ALS. Although much remains to be discovered about the molecular mechanism of SOD1 mediated toxicity, these hypotheses offer new avenues for therapeutic development.
Zitieren
APA
Sangwan, S., & Eisenberg, D. S. (2016). Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis. Postępy Biochemii. https://doi.org/10.18388/pb.2016_37
Vancouver
Sangwan S, Eisenberg DS. Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis. Postępy Biochemii. 2016. doi:10.18388/pb.2016_37
BibTeX
@article{Sangwan2016,
author = {Sangwan, Smriti and Eisenberg, David S},
title = {Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis},
journal = {Postępy Biochemii},
year = {2016},
doi = {10.18388/pb.2016_37}
}
EUVIMED